Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05958485

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation.

Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Glioblastoma Multiforme Astrocytoma Glioblastoma Glioma Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Neuroectodermal Tumors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of glioblastoma multiforme
  • No prior treatment for glioblastoma multiforme
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

  • Female patients who are currently pregnant or nursing
  • Enrolled in another research study
  • Patients who are currently receiving any other investigational drug.

Treatment and study plan

Primary outcomes

  1. Rate of patients who decide to enroll in a glioblastoma multiforme clinical study.

    Time frame: 3 months

  2. Number of glioblastoma multiforme study participants who remain in clinical trial until completion.

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Glioblastoma Multiforme Patients in Clinical Trials: An Examination of Their Clinical Trial Experiences

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Jul 24, 2023
Registry last updated
Jul 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.